DAVITA INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
DAVITA INC. (DVA) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $80.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- DAVITA INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was $259.00K, a 97.25% decline year-over-year.
- DAVITA INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $9.42M.
- DAVITA INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$3.13M, a 235.67% decline year-over-year.
- DAVITA INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $2.31M, a 31.40% decline year-over-year.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month |
|---|---|---|---|
| 2026-06-30 | $80.00K 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | $259.00K 10-Q · filed 2026-05-05 | ||
| 2025-09-30 | $21.90M 10-Q · filed 2025-10-29 | ||
| 2025-06-30 | $20.29M 10-Q · filed 2026-08-04 | ||
| 2025-03-31 | $9.42M 10-Q · filed 2026-05-05 | ||
| 2024-09-30 | -$5.11M 10-Q · filed 2025-10-29 | ||
| 2024-06-30 | -$4.46M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | -$3.13M 10-Q · filed 2025-05-12 | ||
| 2023-09-30 | $3.06M 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | $6.92M 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $2.31M 10-Q · filed 2024-05-02 | ||
| 2022-09-30 | -$6.28M 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | -$1.34M 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $3.36M 10-Q · filed 2023-05-08 | ||
| 2021-09-30 | -$7.38M 10-Q · filed 2022-10-31 | ||
| 2021-06-30 | -$1.20M 10-Q · filed 2022-08-01 | ||
| 2021-03-31 | -$7.97M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |